GlaxoSmithKline (GSK) is reviewing its $1bn global media agency roster in an attempt to tweak its structure to the consumer health joint venture it is building with fellow drug maker
Novartis. The combined effort, is billed as the best of both companies, and GSK will review its media to apply to the statement to its advertising. The Drum understands that Starcom, PHD
and GroupM – all of which have worked with the business in the past - were involved in the final stages of the review.
Read the whole story at The Drum »